[
    [
        {
            "time": "",
            "original_text": "我们研究了三年的上市公司数据，发现了跑赢大盘的秘密",
            "features": {
                "keywords": [
                    "上市公司",
                    "数据",
                    "跑赢大盘",
                    "秘密"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "我们研究了三年的上市公司数据，发现了跑赢大盘的秘密",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-11",
            "original_text": "医药生物2018年三季报总结暨11月投资策略：一阳来复，否极泰来",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "投资策略",
                    "一阳来复",
                    "否极泰来"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物2018年三季报总结暨11月投资策略：一阳来复，否极泰来",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "",
            "original_text": "(互动)华兰生物：四价流感疫苗销售良好 供不应求",
            "features": {
                "keywords": [
                    "华兰生物",
                    "四价流感疫苗",
                    "销售良好",
                    "供不应求"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "(互动)华兰生物：四价流感疫苗销售良好 供不应求",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药三季报总结:医药大数据,成长依旧,估值近前低,正是战略布局好时机",
            "features": {
                "keywords": [
                    "医药",
                    "三季报",
                    "大数据",
                    "成长",
                    "估值",
                    "战略布局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药三季报总结:医药大数据,成长依旧,估值近前低,正是战略布局好时机",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]